Perrigo Advances Most in 14 Months as Sales Beat Estimate

Perrigo Co. surged the most in 14 months in New York as the largest U.S. maker of generic over-the-counter drugs reported quarterly sales that beat analyst forecasts for the first time in a year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.